
Lack of long-lasting effects of mitotane adjuvant therapy in a mouse xenograft model of adrenocortical carcinoma
Keywords: ACC; adrenocortical carcinoma; NOD/SCID; non-obese diabetic/severe combined immunodeficiency; Adrenal cortex; Cancer; Mitotane; Xenografts;